Amelioration of cyclosporine nephrotoxicity by irbesartan, a selective AT1 receptor antagonist

Renal Failure

Volumn 26, Issue 5, 2004, Pages 467-477

  Chander, Vikas ^a   Singh, Devinder ^a   Tirkey, Naveen ^a   Chander, Harish ^b   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Angiotensin II; AT1 receptor antagonist; Cyclosporine A (CsA); Heat shock proteins (HSPs); Irbesartan; Nephrotoxicity; Oxidative stress

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CATALASE; CYCLOSPORIN A; GLUTATHIONE; GLUTATHIONE REDUCTASE; HEAT SHOCK PROTEIN; IRBESARTAN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; HEAT STRESS; HYPOXIA; KIDNEY FUNCTION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; RAT; UREA NITROGEN BLOOD LEVEL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BIPHENYL COMPOUNDS; CYCLOSPORINE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; MODELS, ANIMAL; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; TETRAZOLES;

EID: 5444267958     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200031731     Document Type: Article

References (50)

1. Andoh, T.F.; Bennett, W.M. Chronic cyclosporine nephrotoxicity. Curr. Opin. Nephrol. Hypertens. 1998, 7, 260-270.
2. Taler, S.J.; Textor, S.C.; Canzanello, V.J.; Schwartz, L. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf. 1999, 20, 437-449.
3. Edwards, B.D.; Chalmers, R.J.; O'Driscoll, J.B.; Mitchell, D.M.; Smith, R.J.; Lawson, R.S.; Testa, H.J.; Ballardie, F.W. Angiotensin II as a risk factor for cyclosporine nephrotoxicity in patients with psoriasis. Clin. Nephrol. 1994, 41, 350-356.
4. Shihab, F.S.; Andoh, T.F.; Tanner, A.M.; Noble, N.A.; Border, W.A.; Franceschini, N.; Bennett, W.M. Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy. Kidney Int. 1996, 49, 1141-1151.
5. Murray, B.M.; Paller, M.S.; Ferris, T.F. Effect of cyclosporine administration on renal hemodynamics in conscious rats. Kidney Int. 1985, 28, 767-774.
6. Lanese, D.M.; Conger, J.D. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolate rat renal arterioles. J. Clin. Invest. 1993, 91, 2144-2149.
7. Neild, G.H.; Rocchi, G.; Imberti, L.; Fumagalli, F.; Brown, Z.; Remuzzi, G.; Williams, D.G. Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb. Res. 1983, 32, 373-379.
8. Perico, N.; Benigni, A.; Zoja, C.; Delaini, F.; Remuzzi, G. Functional significance of exaggerated renal thromboxane A2 synthesis induced by A. cyclosporin. Am. J. Physiol. 1986, 251, F581-F587.
9. Butterly, D.W.; Spurney, R.F.; Ruiz, P.; Griffiths, R.; Albrightson, C.; Coffman, T.M. A role for leukotrienes in cyclosporine nephrotoxicity. Kidney Int. 2000, 57, 2586-2593.
10. Knight, J.A.; Cheung, A.K.; Pieper, R.K.; Servilla, K. Increased urinary lipoperoxide levels in renal transplant patients. Ann. Clin. Lab. Sci. 1989, 19, 238-241.
11. Ahmed, S.S.; Napoli, K.L.; Strobel, H.W. Oxygen radical formation during cytochrome P450-catalyzed cyclosporine metabolism in rat and human liver microsomes at varying hydrogen ion concentrations. Mol. Cell. Biochem. 1995, 151, 131-140.
12. Julien, J.; Farge, D.; Kreft-Jais, C.; Guyene, T.T.; Plouin, P.F.; Houssin, D.; Carpentier, A.; Corvol, P. Cyclosporine-induced stimulation of the renin-angiotensin system after liver and heart transplantation. Transplantation 1993, 56, 885-891.
13. Avdonin, P.V.; Cottet-Maire, F.; Afanasjeva, G.V.; Loktionova, S.A.; Lhote, P.; Ruegg, U.T. Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells. Kidney Int. 1999, 55, 2407-2414.
14. Iwai, J.; Kanayama, Y.; Inoue, N.M.; Okamura, M.; Takeda, T. Increased endothelial gene expression of angiotensin AT1A receptor in cyclosporine induced hypertensive rats. Eur. J. Pharmacol. 1993, 245, 341-344.
15. Hannken, T.; Schroeder, R.; Stahl, R.A.; Wolf, G. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int. 1998, 54, 1923-1933.
16. Wilson, S.K. Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res. 1990, 66, 722-734.
17. Ishizaka, N.; Aizawa, T.; Ohno, M. Usui S.; Si, I.; Mori, S.S.; Tang, J.R.; Ingelfinger, S.; Kimura, R.; Nagai. Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of angiotensin II. Hypertension 2002, 39, 122-128.
18. Pelham, H. Heat-shock proteins: coming in from the cold. Nature 1988, 332, 776-777.
19. Aizawa, T.; Ishizaka, N.; Taguchi, J.; Nagai, R.; Mori, I.; Tang, S.S.; Ingelfinger, J.R.; Ohno, M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 2000, 35, 800-806.
20. Muller, E.; Neuhofer, W.; Ohno, A.; Rucker, S.; Thurau, K.; Beck, F.X. Heat shock proteins HSP25, HSP60, HSP72, HSP73 in isoosmotic cortex and hyperosmotic medulla of rat kidney. Pflugers Arch. 1996, 431, 608-617.
21. Smoyer, W.E.; Ransom, R.; Harris, R.C.; Welsh, M.J.; Lutsch, G.; Benndorf, R. Ischemic acute renal failure induces differential expression of small heat shock proteins. J. Am. Soc. Nephrol. 2000, 11, 211-221.
22. Stacchiotti, A.; Rezzani, R.; Angoscini, P.; Corsetti, G.; Bianchi, R. Distribution of heat shock proteins in kidneys of rats after immunosuppressive treatment with cyclosporine A. Acta Histochem. 2001, 103, 167-177.
23. Paslaru, L.; Rallu, M.; Manuel, M.; Davidson, S.; Morange, M. Cyclosporin A induces an atypical heat shock response. Biochem. Biophys. Res. Commun. 2000, 269, 464-469.
24. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biocem. 1979, 95, 351-358.
25. Varley, H. The plasma proteins. In Practical Clinical Biochemistry; Varley, H., Ed.; CBS: Delhi, 1988; 236-238.
26. Jollow, D.J.; Mitchell, L.R.; Zampaglione, N.; Gillete, J.R. Bromobenze induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzeneoxide as the hepatotoxic intermediate. Pharmacology 1974, 11, 151-169.
27. Claiborne, A. CRC handbook of methods for oxygen radical reaserch. Greenwald, R.A., Ed.; CRC Press: Boca Raton, FL, 1985; 283-284.
28. Kono, Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biopsy. 1978, 186, 189-195.
29. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
30. Nath, K.A.; Salahudeen, A.K. Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J. Clin. Invest. 1990, 86, 1179-1192.
31. Satyanarayana, P.S.; Singh, D.; Chopra, K. Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats. Methods Find Exp. Clin. Pharmacol. 2001, 23, 175-181.
32. Erman, A.; Chen-Gal, B.; Zabludowski, J.; Rosenfeld, J.B. Cyclosporin A treatment enhances angiotensin converting enzyme activity in lung and serum of rats. J. Pharm. Pharmacol. 1990, 42, 525-527.
33. Auch-Schwelk, W.; Bossaller, C.; Gotze, S.; Thelen, J.; Fleck, E. Endothelial and vascular smooth muscle function after chronic treatment with cyclosporin A. J. Cardiovasc. Pharmacol. 1993, 21, 435-440.
34. Wolf, G.; Thaiss, F.; Stahl, R.A. Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects. Transplantation 1995, 60, 237-241.
35. Mervaala, E.M.; Pere, A.K.; Lindgren, L.; Laakso, J.; Teravainen, T.L.; Karjala, K.; Vapaatalo, H.; Ahonen, J.; Karppanen, H. Effects of dietary sodium and magnesium on cyclosporin A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. Hypertension 1997, 29, 822-827.
36. Padi, S.S.; Chopra, K. Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity. Pharmacol. Res. 2002, 45, 413-420.
37. Zhong, Z.; Arteel, G.E.; Connor, H.D.; Yin, M.; Frankenberg, M.V.; Stachlewitz, R.F.; Raleigh, J.A.; Mason, R.P.; Thurman, R.G. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am. J. Physiol. 1998, 275, F595-F604.
38. Moss, N.G.; Powell, S.L.; Falk, R.J. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 8222-8226.
39. Mehring, N.; Neumann, K.H.; Rahn, K.H.; Zidek, W. Mechanisms of ciclosporin A-induced vasoconstriction in the isolated perfused rat kidney. Nephron 1992, 60, 477-481.
40. Lanese, D.M.; Falk, S.A.; Conger, J.D. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. Transplantation 1994, 58, 1371-1378.
41. Dunlop, M.E.; Muggli, E.E. Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney Int. 2000, 57, 464-475.
42. Kon, V.; Hunley, T.E.; Fogo, A. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats. Transplantation 1995, 60, 89-95.
43. Haugen, E.N.; Croatt, A.J.; Nath, K.A. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int. 2000, 58, 144-152.
44. Heitzer, T.; Wenzel, U.; Hink, U.; Krollner, D.; Skatchkov, M.; Stahl, R.A.; MacHarzina, R.; Brasen, J.H.; Meinertz, T.; Munzel, T. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C. Kidney Int. 1999, 55, 252-260.
45. Zalba, G.; Beaumont, F.J.; San Jose, G.; Fortuno, A.; Fortuno, M.A.; Etayo, J.C.; Diez, J. Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 2000, 35, 1055-1061.
46. Sechi, L.A.; Grady, E.F.; Griffin, C.A.; Kalinyak, J.E.; Schambelan, M. Distribution of angiotensin II receptor subtypes in rat and human kidney. Am. J. Physiol. 1992, 262, F236-F240.
47. Rajagopalan, S.; Kurz, S.; Munzel, T.; Tarpey, M.; Freeman, B.A.; Griendling, K.K.; Harrison, D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 1996, 97, 1916-1923.
48. Hsu, Y.H.; Chen, J.J.; Chang, N.C.; Chen, C.H.; Liu, J.C.; Chen, T.H.; Jeng, C.J.; Chao, H.H.; Cheng, T.H. Role of reactive oxygen species-sensitive extracellular signal-regulated kinase pathway in angiotensin II-induced endothelin-1 gene expression in vascular endothelial cells. J. Vasc. Res. 2004, 41, 64-74.
49. Hong, H.J.; Chan, P.; Liu, J.C.; Juan, S.H.; Huang, M.T.; Lin, J.G.; Cheng, T.H. Angiotensin II induces endothelin-1 gene expression via extracellular signal-regulated kinase pathway in rat aortic smooth muscle cells. Cardiovasc. Res. 2004, 61, 159-168.
50. Cheng, T.H.; Cheng, P.Y.; Shih, N.L.; Chen, I.B.; Wang, D.L.; Chen, J.J. Involvement of reactive oxygen species in angiotensin II-induced endothelin-1 gene expression in rat cardiac fibroblasts. J. Am. Coll. Cardiol. 2003, 42, 1845-1854.